T., B.; R., R. K.; R., A. C.; P., A.; S., D.; R., J. Effect of Casirivimab-Imdevimab on Mild COVID-19 Patients With Diabetes in Reducing Oxygen Supplementation at 28 Days: An Observational Study. Int J Res Med Sci 2022, 10, 1983-1987.